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Background: A reliable and simple test for the detection of malaria parasite is crucial in providing effective
treatment and therapeutic follow-up, especially in malaria elimination programmes. A comparison of four methods,
including nested polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP) were used
for the malaria diagnosis and treatment follow-up in São Tomé and Príncipe, during a successful pre-elimination
campaign.
Method: During the period September to November 2009, blood samples from 128 children (five to 14 years old)
with temperature ≥38°C (tympanic) in the District of Agua Grande were examined using four different methods, i.e.,
histidine-rich protein 2 (HRP-2) based rapid diagnostic tests (HRP-2-RDTs), optical microscopy, nested PCR, and
LAMP. First-line treatment with artesunate-amodiaquine was given for uncomplicated malaria and intravenous
quinine was given for complicated malaria. Children with persistent positivity for malaria by microscopy, or either
by nested PCR, or by LAMP on day 7 were given second-line treatment with artemether-lumefantrine. Treatment
follow-up was made weekly, for up to four weeks.
Results: On day 0, positive results for HRP-2-RDTs, microscopy, nested PCR, and LAMP, were 68(53%), 47(37%), 64(50%),
and 65(51%), respectively. When nested PCR was used as a reference standard, only LAMP was comparable; both
HRP-2-RDTs and microscopy had moderate sensitivity; HRP-2-RDTs had poor positive predictive value (PPV) and a
moderate negative predictive value (NPV) for the treatment follow-up. Seventy-one children with uncomplicated
malaria and eight children with complicated falciparum malaria were diagnosed based on at least one positive result
from the four tests as well as clinical criteria. Twelve of the 79 children receiving first-line treatment had positive results
by nested PCR on day 7 (nested PCR-corrected day 7 cure rate was 85%). After the second-line treatment,
nested PCR/LAMP-corrected day 28 cure rate was 83% for these 12 children.
Conclusions: HRP-2-RDTs have similar sensitivity as microscopy but less specificity. However, as compared to
nested PCR, the poor sensitivity of HRP-2-RDTs indicates that low parasitaemia may not be detected after
treatment, as well as the low specificity of HRP-2-RDTs indicates it cannot be applied for treatment follow-up.
LAMP has similar sensitivity and specificity to nested PCR. With high PPV and NPV, LAMP is simpler and faster as
compared to nested PCR with the advantage of detecting low parasitaemia becoming a potential point-of-care
test for treatment follow-up.
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Global control efforts have resulted in a reduction in the
incidence of malaria and malarias specific mortality
rates. Transmission of malaria decreased remarkably in
the Republic of São Tomé and Príncipe (STP) since an
integrated malaria control programme was scaled up be-
ginning in 2004 [1,2]. While the decline in malaria mor-
bidity and mortality is notable, potential threat of
malaria epidemics in the status of a low transmission is
of major concern because most of the asymptomatic car-
riers are not treated [3]. Asymptomatic carriers not only
act as reservoirs for malaria transmission but also act as
a risk factor for symptomatic attacks [4-8]. A prerequis-
ite in the attempt to eliminate malaria from an endemic
area is the identification of asymptomatic infections for
treatment [9,10]. Therefore, provision of accurate diag-
nosis as well as prompt and effective treatment is the
core of malaria elimination strategies in the country.
In April 2008, a cross-sectional nationwide malaria
surveillance in STP by use of histidine-rich protein 2
(HRP-2) based rapid diagnostic tests (HRP-2-RDTs)
showed a positive rate of 3.5%, which was further con-
firmed by microscopy [3]. Ninety percent of these mal-
aria positive cases are asymptomatic and only half of
them were cured with artemisinin-combination therapy
(ACT) as confirmed with a follow up study. Follow-up
results were verified by polymerase chain reaction (PCR)
if inconsistent findings were observed between RDT and
blood films. Failure treatment of the asymptomatic mal-
aria carriers attributed to the non-compliance for treat-
ment. This might be responsible for the increase in
malaria cases observed in São Tomé in 2009, which was
reversed after intensification of control measures [3].
The diagnostic testing effort in STP is high. The an-
nual blood examination rate exceeds 30% on average, far
greater than in other countries in the region [2]. How-
ever, current surveillance systems rely on diagnosis by
microscopy or use of RDTs that are not sufficiently spe-
cific or sensitive to detect low-parasite-density infec-
tions. Microscopy and RDTs both become relatively
insensitive at parasite densities below 100 parasites/μl
[11-13]. In addition to the low sensitivity, the high false
positive rate of HRP-2-RDTs is the major limitation to
apply for monitoring of the therapeutic response [14].
To illustrate the importance of the statistical analysis in
the evaluation of the accuracy of malaria diagnostic
tests, Bayesian Latent Class Models were used to esti-
mate the malaria infection prevalence, together with sen-
sitivities, specificities, and predictive values of three
diagnostic tests (HRP-2-RDTs, microscopy and nested
PCR) and found that not only microscopy has poor sen-
sitivity compared to the other tests but also caution
should be taken with the positive predictive values
(PPV) of the HRP-2-RDTs [15].PCR-based molecular methods are good for both sen-
sitivity and specificity but too sophisticated and expen-
sive to be applied in most malaria-endemic countries
[16]. The recently developed loop-mediated isothermal
amplification (LAMP) method is cheaper, simpler, and
faster. The LAMP reaction can be conducted under iso-
thermal conditions and is almost as specific and sensi-
tive as the nested PCR method for Plasmodium-DNA
detection in blood [17-19]. In this study, the role of
LAMP in the malaria diagnosis and therapeutic follow-
up for children with ACT treatment was elucidated by
comparing four diagnostic methods.Methods
Patients and setting
In STP, an integrated malaria control programme was
officially initiated in 2004, and a molecular diagnostic la-
boratory was set in the main island of São Tomé in
2007, following STP Government directives for malaria
control and for ethical clearance throughout the imple-
mentation of the programme. Ethical approval was
obtained from the Ministry of Health of the Democratic
Republic of STP. Informed verbal consent was obtained
from parents/guardians. Most parents/guardians are
illiterate or semi-literate, therefore could not sign a writ-
ten consent. This study took into account that the prin-
ciples of verbal informed consent were the same for
written informed consent. The work was approved by
the Ministry of Health of STP and coordinated by the
Centro Nacional de Endemias (CNE).
During the period September to November 2009, of
191 school children (five to 14 years old) from the dis-
trict of Agua Grande presented to the health stations
with temperature ≥38°C (tympanic), 128 completed four
malaria diagnostic tests (HRP-2-RDTs, microscopy,
nested PCR, and LAMP) and treatment follow-up. The
other 63 febrile children (33%) without completing the
four malaria tests were examined using only HRP-2-
RDTs and/or optical microscopy, but were not included
in this study. Failure to obtain blood spots on the filter
paper from these children for nested PCR and LAMP
was due to the refusal by their parents/guardians for
sample collection.Blood collection
A fingerprick blood sample was obtained for the HRP-2-
RDTs (ICT Malaria-Combo, batch 32185, ICT Diagnos-
tics, South Africa) in addition to thick and thin films. An
additional 3–5 drops (~125 μl) of blood were spotted
onto filter paper (FTA, classic card, Whatman), which
were collected and sent to the molecular diagnostic la-
boratory for subsequent nested PCR and LAMP analysis.
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Thick and thin films were stained with 10% Giemsa for
10 min and microscopic reading on blood films was per-
formed according to CNE diagnostic protocols. Two
trained microscopists examined the blood films simul-
taneously and a third one clarified any discrepancy in
results. A blood film was declared negative when no
parasite was detected in 200 fields. Estimation of parasit-
aemia was made by count of 500 leucocytes and then
expressed as the number of asexual parasites per micro-
litre by assuming a leukocyte count of 8,000/μl. The
microscopists were blinded to any clinical diagnosis,
results of HRP-2-RDTs, nested PCR, and LAMP during
the course of this study.
HRP-2-RDTs
HRP-2-RDTs were prepared and read by nurses and
then read by technicians and/or physicians. All readers
were trained to perform the tests according to manufac-
turer’s instructions. Physicians interpreted and recorded
RDT results as either positive or negative after 15 min;
they were trained to consider faint test lines as positive.
Nested PCR assay
The dry blood spot in a circle size with one inch diam-
eter (~ 125 μl whole blood) on the filter paper was
excised and cut into four quarters, one quarter for
nested PCR and one quarter for the LAMP. For the
nested PCR, DNA was extracted from the quarter dry
blood spot using the QIAamp DNA Blood Mini Kit
(Qiagen Inc., Valencia, CA, USA) according to manufac-
turer’s protocol. The DNA was finally eluted with 50 μl
distilled water. Nested PCR amplification was performed
as described previously by Snounou [20]. In brief, detec-
tion and speciation of Plasmodium is done with a two-
step nested PCR. In the first step, 2.5 μl of extracted
DNA is amplified using genus specific primers; in the
second step, 1 μl of the first PCR amplification product
is further amplified using primers specific for each Plas-
modium species. Ten microlitres of each second PCR
amplified DNA product is electrophoretically resolved
on a 2% agarose gel, stained for 15 min with ethidium
bromide and visualized by UV illumination for analysis
of results.
LAMP assay
For the LAMP, a rapid DNA extraction method for dry
blood spot was modified from the method previously
described by Bereczky et al. [21]. In brief, the quarter
dry blood spot was placed into a 1.5 ml centrifuge tube
and cut into small pieces with a pair of scissors. The fil-
ter pieces were washed twice with 0.5 ml of FTAW Puri-
fication buffer (Life Technologies, Gaithersburg, MD,
USA) for 5 min, twice with 0.5 ml of 10 mM Tris (pH8.0) containing 0.1 mM EDTA for 5 min and again air-
dried on a 56°C heating block. Some 100 μl of double
distilled water added, left to stand for 5 min, and then
heated for 15 min at 100°C. The supernatant, containing
DNA, was subsequently used in visualized LAMP.
One LAMP primer sets for Plasmodium genus and
four species specific LAMP primer sets for each of four
human malaria species reported by Han et al. were used
in this study [18]. The duplicate reaction mixtures (25 μl)
contained 5 μl of the extracted DNA, 1 μl of Bst DNA
polymerase, and 1 μl of fluorescent detection reagent
(Eiken Chemical Co., Ltd., Tokyo, Japan) in 1 × reaction
buffer [20 mM Tris–HCl (pH 8.8), 10 mM KCl, 8 mM
MgSO4, 10 mM (NH4)2SO4, 0.1% Tween 20, 0.8 M Beta-
ine, a 1.4 mM concentration of each dNTP] and the
inner primers FIP and BIP at 1.6 μM, the loop primers
LPF and LPB at 0.8 μM and the outer primers F3 and B3
at 0.2 μM. Amplification was performed at 60°C with a
heat block (Heatblock III, VWR International, Chicago,
IL, USA) for 100 min and then heated at 90°C with a heat
block for 1 min to terminate the reaction. Duplicate
negative control (water) and positive control (water
spiked with DNA) were included in each run.
The positive LAMP reaction was detected by observ-
ing the fluorescence in the reaction tube via naked eye
under a portable UV lamp [22]. In this study, an interval
of 10 min was set to determine the threshold time of the
LAMP reaction. The threshold time for positivity was
found at 60 min and the optimal reaction time was
determined at 100 min, as positive samples with low
parasitaemia showed positivity within 100 min. False
positivity was usually seen when the reaction time was
over 120 min. Two technicians conducting nested PCR
and LAMP independently were blinded to any clinical
diagnosis or results from HRP-2-RDTs/microscopy. Both
nested PCR and LAMP were performed in duplicate. If
the results were inconsistent in each duplicate reaction,
a third run was carried out to confirm the results.
Treatment and follow-up
All patients were seen and the assays, except DNA amp-
lification, were performed on site at the health stations.
Blood spots on the filter paper for nested PCR and
LAMP were transferred to the molecular diagnostic la-
boratory within 1 hr after collection. Blood samples for
nested PCR and LAMP were treated and assayed indi-
vidually on the collection day rather than batched and
performed at a later time. Time to obtain test results
varied depending on the different methods, i.e. 20 min
for HRP-2-RDTs, 60 min for microscopy, 3 hr for
LAMP, and 8 hr for nested PCR. Diagnosis of malaria
was made as a febrile child had at least one positive re-
sult of the four malaria tests. Treatment was started as
soon as possible at the time when the test results were
Table 1 Results of four malaria tests for febrile children
before and after treatment
HRP-2-RDTs Microscopy Nested PCR LAMP
Before treatment
positive: 68 positive: 45 positive: 44 positive: 44
negative: 1 negative: 1
negative: 23 positive: 10 positive: 10
negative: 13 negative: 13
negative: 60 positive: 2 positive: 2 positive: 2
negative: 0 negative: 0
negative: 58 positive: 8 positive: 8
negative: 50 positive: 1
negative: 49
On day 7 after first-line treatment
positive: 33 positive: 6 positive: 6 positive: 6
negative: 0 negative: 0
negative: 27 positive: 1 positive: 1
negative: 26 negative: 26
negative: 46 positive: 1 positive: 1 positive: 1
negative: 0 negative: 0
negative: 45 positive: 4 positive: 3
negative: 1
negative: 41 negative: 41
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treated with a three-day course of artesunate-
amodiaquine at home except for the first dose taken in
front of the nurse’s observation. Children with severe
malaria were admitted to hospital and treated with quin-
ine intravenously. Treatment was switched to oral ad-
ministration as soon as the patient was able to tolerate
it. An additional course of primaquine was given for
vivax malaria. Home treatment was weekly followed up
by a mobile team (consisting of a nurse and a techni-
cian), which actively visited patients by taking blood
samples for HRP-2-RDTs, optical microscopy, nested
PCR and LAMP. Treatment failure was considered if
parasitaemia persisted (microscopy positive), or either
the nested PCR or the LAMP was positive. When treat-
ment failures occurred after one week of initial treat-
ment, artemether-lumefantrine (CoartemW, Novartis,
Swiss) was given, with a three-week follow-up.
Statistical analysis
The sensitivity and specificity of the four methods were
calculated using either microscopy or nested PCR assay
as a reference test. The percentage specificity, sensitivity,
PPV, and negative predictive value (NPV) were calcu-
lated as reported previously [23]. Ninety-five percent
confidence intervals (95%CI) for sensitivity, specificity,
PPV, and NPV were calculated by an exact method for
binomial distribution using SAS statistical package ver-
sion 9.2 (SAS Institute Inc., Cary, NC, USA). In addition,
the degree of agreement between two diagnostic tests
was measured by the concordance response rate (per-
centage of responses with both positive or both negative
results) and a Kappa statistic, which was ranged from 0
if the two tests were completely independent and to 1 if
the two tests had perfect agreement.
Results
Of the 128 febrile children where a complete set of four
malaria tests were carried out, positive results for HRP-
2-RDTs, microscopy, nested PCR, and LAMP, were 68
(53%), 47(37%), 64(50%), and 65(51%), respectively
(Table 1). Among the 68 positives for HRP-2-RDTs,
there were 23 (34%) negatives for microscopy which
were either positive for nested PCR and LAMP (10 chil-
dren) or negative for nested PCR and LAMP (13 chil-
dren). On the other hand, two were HRP-2-RDT
negative but positive for microscopy, nested PCR, and
LAMP. Among the 45 positives for both HRP-2-RDTs
and microscopy, one was negative for both nested PCR
and LAMP. Of the 23 negatives for microscopy but posi-
tives for HRP-2-RDTs, 10 were positive for both nested
PCR and LAMP. Fourteen children with negative nested
PCR were positive for falciparum malaria by HRP-2-
RDTs (Table 1).Among the 58 children with negative results for both
HRP-2-RDTs and microscopy, eight were positive for
both nested PCR and LAMP, but one with negative
nested PCR was positive for LAMP (the only one single
infection with Plasmodium malariae found in this
study). Species identification based on nested PCR and
LAMP showed that 62 children exhibited single infec-
tion with Plasmodium falciparum and two children were
mixed infections (one with P. falciparum and P. malar-
iae, the other with P. falciparum and Plasmodium
vivax). Optical microscopy showed that the parasite
density ranged widely, 100–100,000/ul for 47 children
on day 0, with a narrower range of 100–10,000/ul in
seven children on day 7.
Malaria positive cases were defined from one positive
result out of the four tests. Taking together, 79 children
were positive for malaria; 71 uncomplicated and eight
complicated. The initial treatment was followed up on
day 7, numbers of the positive results for HRP-2-RDT,
microscopy, nested PCR, and LAMP, were 33, seven, 12,
and 11, respectively (Table 1). Of the 79 children receiv-
ing treatment, 67 children with negative microscopy
were also negative for nested PCR and LAMP, which
was considered as effective treatment (a cure rate of 91%
assayed by microscopy but 85% corrected by nested PCR
and 86% by LAMP). Further weekly follow-up for these
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the children’s parents for sample collections. On the
other hand, 12 children found positive for nested PCR
on day 7 after the initial treatment were regarded as
treatment failure and received a second-line treatment
with artemether-lumefantrine (Table 2). Children A and
K did not complete the first-line treatment because their
parents/guardians considered that the children had
improved their health conditions. On day 14 (one week
after the second-line treatment), cure rate for these 12
children reached 100% if based upon microscopy but
92% if corrected by nested PCR and LAMP (Table 2).
On day 28, cure rate showed 100% if determined by mi-
croscopy but 83% if corrected by nested PCR and
LAMP. Child A remained malaria positive constantly by
nested PCR and LAMP throughout the four-week fol-
low-up, despite a good response to the second-line treat-
ment as judged by microscopy. This indicates the
possible existence of falciparum parasites with lower sus-
ceptibility to the drug treatment. Child K who did not
take the full course of first-line treatment was negative
by microscopy but positive by nested PCR and LAMP
on day 7, had a temporary response to the second-line
treatment on day 14 when evaluated by nested PCR and
LAMP, suggesting again presence of falciparum parasites
that do not respond to the treatment, demanding a more
detailed study in drug resistance in the area.
To elucidate the accuracy of the four tests for malaria
diagnosis, either microscopy or nested PCR is used as a
gold standard and sensitivity, specificity, PPV, and NPV
are the indicators for comparison. When microscopy isTable 2 Results of four malaria tests for patients
receiving second-line malaria treatment on day 7 with
weekly follow-up
Case HRP-2-RDTs Microscopy Nested PCR LAMP
7 14 21 28 7 14 21 28 7 14 21 28 7 14 21 28
A + + - - + - - - + + + + + + + +
B + + + + + - - - + - - - + - - -
C + + + + + - - - + - nd - + - nd -
D + + + - + - - - + - - - + - - -
E + + - - + - - - + - - - + - - -
F + + - - + - - - + - - - + - - -
G + + + + - - - - + - - - + - - -
H - - - - + - - - + - - - + - - -
I - - - - - - - - + - - - + - - -
J - - + + - - - - + - - - + - - -
K - - - + - - - - + - + + + - + +
L - - nd - - - nd - + - nd - - - nd -
Case I was single infection with P. malariae; case L was mixed infection with
P. falciparum and P. vivax; other cases were monoinfection with P. falciparum.
+: positive; -: negative.
nd: not done.used as a gold standard, both specificity and PPV were
moderate for HRP-2-RDTs, nested PCR, and LAMP
(Table 3). When nested PCR is used as a gold standard,
only LAMP is comparable (Kappa = 0.98, Table 4); HRP-
2-RDTs revealed moderate sensitivity (84%, 95%CI: 75.3-
90.6%), specificity (78%, 95%CI: 68.6-85.7%), PPV (79%,
95%CI: 69.7-86.5%), and NPV (83%, 95%CI: 74.2-89.8%).
Microscopy also had moderate sensitivity (72%, 95%CI:
62.1-80.5%) and NPV (78%, 95%CI: 68.6-85.7%).
For the therapeutic follow-up, HRP-2-RDTs had very
poor PPV (18-21%) no matter that microscopy or nested
PCR was used as a gold standard (Tables 3 and 4). Con-
sidering the poor performance of microscopy as the gold
standard, both nested PCR and LAMP exhibited moder-
ate PPV (Table 3). When nested PCR acted as a refer-
ence standard, LAMP showed excellent PPV and NPV,
in terms of evaluating the efficacy of treatment (Table 4).
Discussion
This study has shown that LAMP with high PPV and
NPV as compared to nested PCR, can be applied for
malaria therapeutic follow-up. HRP-2-RDTs have similar
sensitivity as microscopy but less specificity, which can
either induce to underdiagnosis because of the moderate
NPV or over-diagnosis due to the poor PPV.
Methods for the detection of malaria are central to an
elimination programme. Current diagnostic methods ap-
plied in endemic areas are either time-consuming, or in-
sensitive for use in conditions of low infection [13,24].
Optical microscopy is often taken as the gold standard
for diagnosis, but its limited sensitivity due to low para-
sitaemia, common in low endemic areas, makes it unre-
liable [25,26]. A previous study using Bayesian latent
class models revealed the danger of statistical analysis
based on microscopy as a reference test [15]. Using
nested PCR as a gold standard, this study has shown that
good agreement with nested PCR is achieved with
LAMP. LAMP for molecular detection of P. falciparum
has been compared with other diagnostic tests, but both
sensitivity and specificity of LAMP varied in different
studies [23,27-30]. A recent report on the evaluation of
LAMP for malaria diagnosis at a field clinic found that
PPV and NPV of LAMP were 100% and 98%, respect-
ively, which are similar to our results, indicating that
LAMP is an effective tool for malaria diagnosis in a field
setting [29].
The inconsistent results between nested PCR and
LAMP were found in two cases (one with PCR negative
but LAMP positive while one with PCR positive but
LAMP negative). This discrepancy may be expected
when both nested PCR and LAMP are performed by
two technicians independently. It has been reported that
the sensitivity of a given PCR assay varies between la-
boratories. Although, the variations are relatively minor,







Sensitivity Specificity PPV NPV
(95% CI) (95% CI) (95% CI) (95% CI)
Before treatment
HRP-2-RDTs 80% 96 72 66 97
(0.62) (90.1, 98.9) (62.1, 80.5) (55.9, 75.2) (91.5, 99.4)
Nested PCR 85% 98 78 72 98
(0.70) (93.0, 99.8) (68.8, 85.7) (62.1, 80.5) (93.0, 99.8)
LAMP 84% 98 77 71 98
(0.69) (93.0, 99.8) (67.5, 84.8) (61.1, 79.6) (93.0, 99.8)
On day 7 after first-line treatment
HRP-2-RDTs 65% 86 63 18 98
(0.18) (77.6, 92.1) (52.8, 72.4) (11.0, 27.0) (93.0, 99.8)
Nested PCR 94% 100 93 58 100
(0.70) (96.4, 100) (86.1, 97.1) (47.7, 67.8) (96.4, 100)
LAMP 95% 100 94 64 100
(0.75) (96.4, 100) (87.4, 97.8) (53.8, 73.4) (96.4, 100)
Percentage of agreement was measured by the percentage of test results with both positive or with both negative responses and its corresponding Kappa
statistic (the higher the better; see texts in statistical analysis).
HRP-2-RDTs, histidine-rich protein 2 based rapid diagnostic tests; Nested PCR, nested polymerase chain reaction; LAMP, loop-mediated isothermal amplification;
PPV, positive predictive value; NPV, negative predictive value.







Sensitivity Specificity PPV NPV
(95% CI) (95% CI) (95% CI) (95% CI)
Before treatment
HRP-2-RDTs 81% 84 78 79 83
(0.63) (75.3, 90.6) (68.6, 85.7) (69.7, 86.5) (74.2, 89.8)
Microscopy 85% 72 98 98 78
(0.70) (62.1, 80.5) (93.0, 99.8) (93.0, 99.8) (68.6, 85.7)
LAMP 99% 100 98 98 100
(0.98) (96.4, 100) (93.0, 99.8) (93.0, 99.8) (96.4, 100)
On day 7 after first-line treatment
HRP-2-RDTs 61% 58 61 21 89
(0.11) (47.7, 67.8) (50.7, 70.6) (13.5, 30.3) (81.2, 94.4)
Microscopy 94% 58 100 100 93
(0.70) (47.7, 67.8) (96.4, 100) (96.4, 100) (86.1, 97.1)
LAMP 99% 92 100 100 99
(0.95) (84.8, 96.5) (96.4, 100) (96.4, 100) (94.6, 99.9)
Percentage of agreement was measured by the percentage of test results with both positive or with both negative responses and its corresponding Kappa
statistic (the higher the better; see texts in statistical analysis).
HRP-2-RDTs, histidine-rich protein 2 based rapid diagnostic tests; Nested PCR, nested polymerase chain reaction; LAMP, loop-mediated isothermal amplification;
PPV, positive predictive value; NPV, negative predictive value.
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and mixed infections [31]. These problems may also
occur in LAMP based assays. The case with LAMP posi-
tive but nested PCR negative was falciparum malaria
with extreme low parasitaemia while the case with
nested PCR positive but LAMP negative harboured a
mixed infection with P. falciparum and P. vivax. Low
parasitaemia and mixed infection may limit the detec-
tion, even by use of molecular methods, but this cannot
be the excuse for the contradiction in results between
LAMP and nested PCR.
It has been well documented that blood compositions,
such as haemoglobin and IgG/IgM, can interfere with
the performance of PCR [32-34]. A rapid extraction of
DNA from filter paper may be favourable for LAMP but
a conventional method is needed for the nested PCR. In
practice, the risk of variation in results increases as in
the case of nested PCR where more steps in the prepar-
ation of DNA purification are required. Although errors
in the performance of nested PCR and LAMP cannot be
excluded, a good participation of well-trained techni-
cians and good controls greatly reduce mistakes. To
make sure no amplification in the negative controls, the
three- room rule has been applied for the setup; one for
DNA extraction, one for reaction preparation, and one
for amplification – cycler (PCR) and heater (LAMP).
The three- room policy has minimized the false positiv-
ity caused by contamination. The cause for discrepancy
in results between nested PCR and LAMP is not clear
and no available tests can verify the difference unless
they were reconciled and repeated. The need of accurate,
sensitive, affordable and easy to run for the LAMP war-
rants further investigation. More sensitive LAMP assay
to detect malaria parasites targeted mitochondria DNA
has been developed [27].
Malaria can be over-diagnosed if febrile children had
positive HRP-2-RDTs but negative microscopy. One
third of children (23/68) with positive HRP-2-RDTs were
negative by microscopy and this can be attributed to low
parasite density or to the delayed clearance of circulating
HRP-2 antigen. Further verification by molecular tests,
positive results from nested PCR and LAMP (10 out of
23) provided the evidence for the low parasitaemia while
negative results from nested PCR and LAMP (13 out of
23) explained the possibility for the residual circulating
HRP-2 antigens. Other causes for false-positive RDT
results, such as gametocytaemia and the presence of the
serum rheumatoid factor cannot be excluded [24,35-37].
At follow-up on day 7, these 13 children revealed the
same test results as prior to the initial treatment which
suggests over-treatment for malaria. Although the causes
of fever origin were unknown, these children became
afebrile and left without any sequelae after the anti-
malaria treatment.It has been well documented that individuals with low
parasite density act as reservoirs for transmission [4,6,8]
and are also more prone to having malaria attack [5,7]
In this study, all febrile children with positive RDTs were
treated as malaria at the first instance because patients
with positive RDTs in a suspected epidemic can be
highly suggestive of falciparum malaria [3]. In addition,
it is not wise to delay the treatment for falciparum mal-
aria until the nested PCR result is available, which takes
several hours. LAMP is simpler and faster and can be a
potential tool to replace nested PCR, but it still takes
time to obtain results as the laboratory is usually distant
from collection points. While the costs for the LAMP
assay are only about a tenth of that for the conventional
PCR [17], the reagents and enzymes are still expensive
and may restrict its use in malaria-endemic areas. Future
development of RDT-based LAMP for the malaria diag-
nosis should always take into account the affordability
by the users in resource-limited countries [30]. With im-
provement of infra-structures of health system in the fu-
ture, LAMP can be useful as a point-of-care test.
In tropical Africa, the differentiation of malaria from
other causes of fever in the absence of microscopy is no-
toriously difficult. Even febrile children were malaria
positive by microscopy it is a challenge to distinguish
children who really do have severe malaria from those
who have severe febrile illness but coincidental parasit-
aemia, who may have another infection. Although recent
studies reported a strong correlation between plasma
PfHRP2, disease severity, and outcome, and suggest that
plasma PfHRP2 is a prognostic indicator in African chil-
dren with severe falciparum malaria [38,39], measure-
ment of plasma PfHRP2 was not available in this study.
On the other hand, current HRP2-based RDTs cannot
distinguish between asexual parasitaemia and gametocy-
taemia, which also contribute to the production of
HRP2. Evidence showed that the RDT line intensity did
not correlate with parasite density, days of parasitaemia,
or disease severity [40]. Therefore, RDTs cannot be con-
sidered quantitative.
False-negative malaria RDT results can occur due to a
prozone-like effect in high-density infections [41]. In this
study, two children with high parasite density
(~100,000/μl) were negative for HRP-2-RDTs but posi-
tive for microscopy, nested PCR, and LAMP. Their
initial negative HRP-2-RDT became positive after a 10-
dilution of blood was made. However, low parasitaemia
below the detection limit of microscopy is the major
cause for false-negative HRP-2-RDT results found in
this study. False negativity due to the genetic hetero-
geneity of PfHRP-2 expression is also possible. A re-
cent report showed that falciparum malaria parasites
in Africa fail to produce HRP-2 can cause patent
bloodstream infections and false-negative RDT results,
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Artesunate plus amodiaquine combination is one ACT
recommended by the WHO for use in malaria control
programmes and a first line treatment for African chil-
dren with uncomplicated malaria [2]. This recommenda-
tion is now a national policy in STP. Clinical trials have
shown that artesunate-amodiaquine is a highly effica-
cious and safe anti-malarial drug [43]. However, poor ad-
herence cannot achieve its desired therapeutic outcome.
Too many tablets is inconvenient for children and
patients/guardians may discontinue the treatment when
they think their children feel better after fever subsides.
A new formulation of artesunate-amodiaquine (Win-
throp) based on one tablet per day administration, may
improve compliance.
The efficacy of the six-dose in three-day regimen of
artemether/lumefantrine has been confirmed in many
different patient populations around the world, cure
rates on 7,14 and 28 days exceeding 95% in the evaluable
population [44]. The 14-day follow-up revealed that the
cure rate for second-line treatment was 100% by micros-
copy but 92% corrected by nested PCR and LAMP. The
28-day follow-up showed the cure rate of 100% by mi-
croscopy, but 83% corrected by nested PCR and LAMP.
The lower efficacy of second-line treatment observed in
this study can be attributed to the presence of drug-
resistant parasites which may contribute to the spread of
drug-resistant mutant strains of the malaria parasite,
thus complicating the treatment scenario.
The weakness of this study was that it was not ran-
domized and the sample size was relatively small. In
addition, both nested PCR and LAMP detect the amp-
lification of target DNA while RDTs is antigen capture
and microscopy is morphological identification. With
the different targets detected, comparisons among
these four different tests may be limited. Latent class
models have been widely used to estimate diagnostic
tests performance measures, such as sensitivity and
specificity, as well as the diseases prevalence, in the
absence of a gold standard or perfect reference test. In
spite of being frequently used as a reference technique,
microscopy is in fact an imperfect gold standard, espe-
cially in low parasitaemia as in this malaria control is-
land [15].
Although this study was carried out during the
rainy season with a short period time and only older
children were enrolled, malaria positive rate in febrile
children was high (1/3 by microscopy or 1/2 by the
nested PCR), which strongly indicates a high risk of
malaria epidemics in a low transmission area, like São
Tomé. After an intensive treatment and follow-up,
there was no mortality observed among these febrile
children.Conclusions
In developing countries malaria diagnosis mainly
depends on microscopy or RDTs. For an elimination
programme in malaria-endemic areas, however, current
HRP-2-RDTs and optical microscopy are not adequate
enough to evaluate the efficacy of treatment or detect
low parasitaemia, especially in people with asymptomatic
infection. Both sensitivity and specificity of the LAMP
assay were similar to those of nested PCR. With high
PPV and NPV, LAMP was the best method of the four
tests for malaria diagnosis during a follow-up study.
LAMP can be further developed as a point-of-care test,
which is a valuable surveillance tool for guiding elimin-
ation efforts.
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